Search

everythinglearnresearchcommunity

for

Search:↓

The article concludes that proper injection techniques and patient education can prevent serious skin reactions from multiple sclerosis medications.

Tildrakizumab significantly improved psoriasis symptoms and well-being over 52 weeks.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

Dermoscopy helped diagnose discoid lupus erythematosus in two patients without needing skin biopsies.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Intralesional triamcinolone acetonide is effective and safe for treating early to mid-stage traction alopecia.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.

UVA1-light therapy successfully treated a child's skin condition, mycosis fungoides.

The consensus provides guidelines for safely stopping danazol in hereditary angioedema treatment.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Pegylated interferon-alpha 2a can cause a rare nerve disorder, but early treatment can lead to full recovery.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

IL-25 helps heal diabetic wounds by improving blood vessel and skin cell functions.

High-dose intravenous iron therapy doesn't interfere with treatment improvements in IBD patients with iron deficiency anemia.

Dunaliella salina microalgae is safe to eat and may boost health.

Transplanting small skin grafts can successfully repigment leukoderma.

Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.

Biologics show promise in treating various stubborn skin diseases, but more research and better reimbursement criteria are needed.

Tea tree oil is more effective for treating human demodicosis than other treatments.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Umbilical cord blood transplantation improved the boy's symptoms despite complications.

Anti-IL17A therapy reduced venous leg ulcer size by 64% without major side effects.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

Infliximab improved skin and bowel symptoms in Crohn's disease but caused side effects and the disease returned after stopping treatment.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.